阻断膜联蛋白A2可预防糖尿病视网膜病变小鼠模型的早期微血管病变
研究在糖尿病Akita小鼠和氧诱导视网膜病变(OIR)小鼠中测试Anxa2基因敲除及玻璃体腔注射抗A2抗体对周细胞丢失和视网膜新生血管的影响。结果显示基因敲除和免疫阻断A2均防止糖尿病小鼠视网膜周细胞耗竭,抗A2还减少OIR模型的血管闭塞和新生血管,联合抗VEGF效果增强。作者认为靶向A2单用或联合抗VEGF在小鼠中有效,可能减缓人类糖尿病视网膜血管病变进展。
要点
- Anxa2基因敲除和抗A2抗体均防止糖尿病Ins2AKITA小鼠视网膜周细胞耗竭。
- 抗A2抗体减少OIR模型血管闭塞和新生血管,联合抗VEGF时效果增强。
- 作者认为靶向A2单用或联合抗VEGF在小鼠中有效,可能减缓人类糖尿病视网膜血管病变进展。
核心结论
- 靶向A2的治疗方法单用或联合抗VEGF治疗在小鼠中有效,可能减缓人类糖尿病视网膜血管病变的进展。
研究设计与样本
- 分析伴或不伴Anxa2全局敲除的糖尿病Ins2AKITA小鼠,以及2、4、6月龄接受玻璃体腔抗A2 IgG或对照抗体的Ins2AKITA小鼠,7月龄时评估视网膜周细胞丢失。
- 在新生小鼠OIR模型中评估玻璃体腔抗A2对视网膜新生血管面积、血管闭塞面积和新生血管簇计数的影响。
主要发现
- Anxa2基因敲除和A2免疫阻断均防止糖尿病Ins2AKITA小鼠视网膜周细胞耗竭。
- 阻断A2减少OIR模型中血管闭塞和新生血管。
- 联合使用抗VEGF和抗A2抗体时该效果增强。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We examined the role of annexin A2 (A2) in the development of diabetic retinal vasculopathy by testing the effect of Anxa2 gene deletion as well as administration of anti-A2 antibodies on pericyte dropout and retinal neovascularization in diabetic Akita mice, and in mice subjected to oxygen-induced retinopathy. METHODS: We analyzed diabetic Ins2AKITA mice with or without global deletion of Anxa2, as well as Ins2AKITA mice that received intravitreal anti-A2 IgG or control antibody at 2, 4, and 6 months, for retinal pericyte dropout at 7 months of age. In addition, we assessed the effect of intravitreal anti-A2 on oxygen-induced retinopathy (OIR) in neonatal mice by quantifying retinal neovascular and vaso-obliterative area, and by enumeration of neovascular tufts. RESULTS: Both deletion of the Anxa2 gene and immunologic blockade of A2 prevented pericyte depletion in retinas of diabetic Ins2AKITA mice. Blockade of A2 also reduced vaso-obliteration and neovascularization in the OIR model of vascular proliferation. This effect was amplified when a combination of antivascular endothelial growth factor (VEGF) and anti-A2 antibodies was used. CONCLUSIONS: Therapeutic approaches that target A2, alone or in combination with anti-VEGF therapy, are effective in mice, and may also curtail the progression of retinal vascular disease in humans with diabetes.
引用
- Dallacasagrande V, Liu W, Almeida D, et al. Blockade of Annexin A2 Prevents Early Microvasculopathy in Murine Models of Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2023. PMID: 37103008. doi:10.1167/iovs.64.4.33
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。